bioengineer.org /3 weeks ago

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 stabilizes the glutamine transporter ASCT2 by blocking SPOP-driven ubiquitin-proteasome degradation, sustaining AKT/mTORC1 signaling in hepatocellular carcinoma cells.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.